Jan Danser

Jan Danser is a Full Professor in the Department of Internal Medicine at Erasmus MC, Faculty of Medicine. His academic career is deeply rooted in cardiovascular and renal pharmacology, with a strong emphasis on the renin-angiotensin-aldosterone system (RAAS) and its role in hypertension and preeclampsia.

His research interests span hypertension, RAAS modulation, antihypertensive drug development, preeclampsia, and placental physiology. He has made significant contributions to understanding how hormonal and pharmacological agents influence blood pressure, particularly through receptor-level interactions and novel therapeutic approaches such as siRNA and incretin-based therapies.

The recent trend in his publications shows a focus on innovative treatments for hypertension, including gene-targeted therapies and metabolic interventions, while also extending into maternal cardiovascular health and the impact of cannabis use during pregnancy. These works appear in top-tier journals like Hypertension and Journal of Hypertension, reflecting his influence in the field.

• Renin-Angiotensin-Aldosterone System (RAAS)
• Blood Pressure Regulation
• Pharmacological Interventions in Hypertension
• Preeclampsia and Long-term Cardiovascular Risk
• Endocannabinoid Signaling in Placenta
• Incretin-Based Therapies

Prof. Danser has supervised 53 junior researchers and students, indicating a strong commitment to academic mentorship. His research is supported by extensive collaboration, as evidenced by co-authorship on numerous high-impact publications. There is no indication of formal scientific awards in the provided text, though his citation metrics and publication volume suggest recognition within the scientific community.

He is actively involved in research, with recent publications in 2025, and shows no signs of retirement or part-time status. No personal email addresses or educational history are available in the provided content.